BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37511390)

  • 1.
    Quimque MTJ; Go AD; Lim JAK; Vidar WS; Macabeo APG
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis and antitubercular activity of 4-alkoxy-triazoloquinolones able to inhibit the M. tuberculosis DNA gyrase.
    Carta A; Bua A; Corona P; Piras S; Briguglio I; Molicotti P; Zanetti S; Laurini E; Aulic S; Fermeglia M; Pricl S
    Eur J Med Chem; 2019 Jan; 161():399-415. PubMed ID: 30384044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spiropyrimidinetrione DNA Gyrase Inhibitors with Potent and Selective Antituberculosis Activity.
    Govender P; Müller R; Singh K; Reddy V; Eyermann CJ; Fienberg S; Ghorpade SR; Koekemoer L; Myrick A; Schnappinger D; Engelhart C; Meshanni J; Byl JAW; Osheroff N; Singh V; Chibale K; Basarab GS
    J Med Chem; 2022 May; 65(9):6903-6925. PubMed ID: 35500229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, antimycobacterial activities and phototoxic evaluation of 5H-thiazolo[3,2-a]quinoline-4-carboxylic acid derivatives.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Med Chem; 2008 Sep; 4(5):482-91. PubMed ID: 18782045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benzothiazinone-piperazine derivatives as efficient Mycobacterium tuberculosis DNA gyrase inhibitors.
    Chandran M; Renuka J; Sridevi JP; Pedgaonkar GS; Asmitha V; Yogeeswari P; Sriram D
    Int J Mycobacteriol; 2015 Jun; 4(2):104-15. PubMed ID: 26972878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based drug repurposing to inhibit the DNA gyrase of Mycobacterium tuberculosis.
    Gl B; Rajput R; Gupta M; Dahiya P; Thakur JK; Bhatnagar R; Grover A
    Biochem J; 2020 Nov; 477(21):4167-4190. PubMed ID: 33030198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of novel quinoline-aminopiperidine hybrid analogues as Mycobacterium tuberculosis DNA gyraseB inhibitors.
    Medapi B; Renuka J; Saxena S; Sridevi JP; Medishetti R; Kulkarni P; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2015 May; 23(9):2062-78. PubMed ID: 25801151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimycobacterial activities of novel 2-(sub)-3-fluoro/nitro-5,12-dihydro-5-oxobenzothiazolo[3,2-a]quinoline-6-carboxylic acid.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem; 2008 Mar; 16(6):3408-18. PubMed ID: 18304818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Aminoquinoline derivatives as novel Mycobacterium tuberculosis GyrB inhibitors: Structural optimization, synthesis and biological evaluation.
    Medapi B; Suryadevara P; Renuka J; Sridevi JP; Yogeeswari P; Sriram D
    Eur J Med Chem; 2015 Oct; 103():1-16. PubMed ID: 26318054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of acridine derivatives as selective Mycobacterium tuberculosis DNA gyrase inhibitors.
    Medapi B; Meda N; Kulkarni P; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2016 Feb; 24(4):877-85. PubMed ID: 26787274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
    Jeankumar VU; Renuka J; Santosh P; Soni V; Sridevi JP; Suryadevara P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013; 70():143-53. PubMed ID: 24148991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Yogeeswari P; Sriram D; China A; Nagaraja V
    Eur J Med Chem; 2009 Jan; 44(1):345-58. PubMed ID: 18502542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid.
    Murugesan D; Palaniappan S; Perumal Y; Arnab C; Valakunja N; Sriram D
    Int J Antimicrob Agents; 2008 Apr; 31(4):337-44. PubMed ID: 18359434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three-component, one-pot synthesis of anthranilamide Schiff bases bearing 4-aminoquinoline moiety as Mycobacterium tuberculosis gyrase inhibitors.
    Salve PS; Alegaon SG; Sriram D
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1859-1866. PubMed ID: 28274627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase.
    Sriram D; Aubry A; Yogeeswari P; Fisher LM
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2982-5. PubMed ID: 16554151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient synthesis and biological screening of benzofuran and benzo[d]isothiazole derivatives for Mycobacterium tuberculosis DNA GyrB inhibition.
    Reddy KI; Srihari K; Renuka J; Sree KS; Chuppala A; Jeankumar VU; Sridevi JP; Babu KS; Yogeeswari P; Sriram D
    Bioorg Med Chem; 2014 Dec; 22(23):6552-6563. PubMed ID: 25456076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of gyrase B as a drug target in Mycobacterium tuberculosis.
    Chopra S; Matsuyama K; Tran T; Malerich JP; Wan B; Franzblau SG; Lun S; Guo H; Maiga MC; Bishai WR; Madrid PB
    J Antimicrob Chemother; 2012 Feb; 67(2):415-21. PubMed ID: 22052686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mycobacterium Tuberculosis (MTB) GyrB inhibitors: An attractive approach for developing novel drugs against TB.
    Chaudhari K; Surana S; Jain P; Patel HM
    Eur J Med Chem; 2016 Nov; 124():160-185. PubMed ID: 27569197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel N-linked aminopiperidine-based gyrase inhibitors with improved hERG and in vivo efficacy against Mycobacterium tuberculosis.
    Hameed P S; Patil V; Solapure S; Sharma U; Madhavapeddi P; Raichurkar A; Chinnapattu M; Manjrekar P; Shanbhag G; Puttur J; Shinde V; Menasinakai S; Rudrapatana S; Achar V; Awasthy D; Nandishaiah R; Humnabadkar V; Ghosh A; Narayan C; Ramya VK; Kaur P; Sharma S; Werngren J; Hoffner S; Panduga V; Kumar CN; Reddy J; Kumar K N M; Ganguly S; Bharath S; Bheemarao U; Mukherjee K; Arora U; Gaonkar S; Coulson M; Waterson D; Sambandamurthy VK; de Sousa SM
    J Med Chem; 2014 Jun; 57(11):4889-905. PubMed ID: 24809953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ofloxacin derivatives: synthesis, antimycobacterial and toxicological evaluation.
    Dinakaran M; Senthilkumar P; Yogeeswari P; China A; Nagaraja V; Sriram D
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1229-36. PubMed ID: 18068979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.